[go: up one dir, main page]

DE4113346A1 - Aq. lotion for strengthening and regeneration of hair-growth - comprises ethanol@, phospholipid(s) (derived from soya bean oil) oil, and/or grease - Google Patents

Aq. lotion for strengthening and regeneration of hair-growth - comprises ethanol@, phospholipid(s) (derived from soya bean oil) oil, and/or grease

Info

Publication number
DE4113346A1
DE4113346A1 DE19914113346 DE4113346A DE4113346A1 DE 4113346 A1 DE4113346 A1 DE 4113346A1 DE 19914113346 DE19914113346 DE 19914113346 DE 4113346 A DE4113346 A DE 4113346A DE 4113346 A1 DE4113346 A1 DE 4113346A1
Authority
DE
Germany
Prior art keywords
phospholipids
oil
preparation according
approx
vol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
DE19914113346
Other languages
German (de)
Inventor
Erfinder Wird Nachtraeglich Benannt Der
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LANG ERICH 8000 MUENCHEN DE
Original Assignee
LANG ERICH 8000 MUENCHEN DE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LANG ERICH 8000 MUENCHEN DE filed Critical LANG ERICH 8000 MUENCHEN DE
Priority to DE19914113346 priority Critical patent/DE4113346A1/en
Publication of DE4113346A1 publication Critical patent/DE4113346A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34—Alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/678—Tocopherol, i.e. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A61K8/983—Blood, e.g. plasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Aq. lotion for strengthening and regenerating hair growth, comprises ethanol, phospholipids (derived from soya bean oil), oil and/or grease. Aq. lotion is in the form of a microemulsion contg. a) approx. 25 vol.%, pref. 5-20 vol.% and esp. approx. 20 vol.% ethanol, b) approx. 3 wt.%, pref 1-25 wt.% and esp. approx. 2 wt.% soya-phospholipides and c) approx. 5 wt.%, pref. 1-4 wt.% and esp. 3 wt.% oil and/or grease. Oil and/or grease content is based on (un)satd fatty acids eg palmitic, stearic, oleic, linoleic, linolenic acid. In addn, one or more of up to 5 wt.% lyso-phosphatidyl choline and up to 1 wt.% of soya-phospholipid derivs. eg. phosphatidic acid, phosphatidylinositol, sterol (derivs), N-acyl-phosphatidyl-ethanolamine, usual lipid fractions may be added. Other additives include up to approx. 2 vol.% blood dialysate eg. 'Philocell' (RTM and vitamins esp. vitamin A and/or vitamin E, D-panthenol and/or alpha-bisabolol. USE/ADVANTAGE - Lotion is in the form of v. stable microemulsion which does not separate out during storage. In an example, compsn. comprising approx. 20 vol.% ethanol, approx. 2 wt.% purified soya-phospholipids contg. max 5% lyso-phosphatidyl-choline and max. 1% other phospholipids, max. 3% fatty acid component (comprising 20% palmitic and stearic, 10% oleic, 62% linoleic, 8% linolenic acid), vitamin E (acetate), D-panthenol, alpha-bisabolol, max. 2% 'Philocell

Description

Kenntnis der Probleme, die bei der Kräftigung und Regeneration von Kopfhaar bestehen, darf vorausgesetzt werden.Knowledge of the problems involved in strengthening and regeneration of hair, may be assumed.

Gegenstand der vorliegenden Erfindung ist eine wässerige Zube­ reitung zur Kräftigung und Regeneration des Haarwuchses, die durch einen Gehalt anThe present invention is an aqueous Zube for the strengthening and regeneration of hair growth, the by a salary

  • - Ethanol,Ethanol,
  • - Phospholipide und- Phospholipids and
  • - Öle und/oder Fette gekennzeichnet ist.- oils and / or fats is marked.

Die Phospholipide können auch als Phospholipid-Liposome (Bilayer-Vesikel) bezeichnet werden, wobei sie üblicherweise mit einer mittleren Teilchengröße von 150 bis 200 nm vorliegen.The phospholipids may also be called phospholipid liposomes (Bilayer vesicles), where they usually with an average particle size of 150 to 200 nm.

Der Ethanolgehalt kann bis zu etwa 25 Vol.-% betragen. Vorzugs­ weise beträgt er 5 bis 20 Vol.-% und insbesondere etwa 20 Vol.-% (jeweils bezogen auf die Zubereitung).The ethanol content can be up to about 25% by volume. virtue example, it is 5 to 20 vol .-% and in particular about 20 vol .-% (in each case based on the preparation).

Es können Phospholipide auf Basis von Soyabohnenöl (Soya- Phospholipide) vorgesehen werden. Dabei kann die Soya-Phospholi­ pid-Menge bis zu etwa 3 Gew.-% betragen. Vorzugsweise beträgt sie 1 bis 3,5 Gew.-% und insbesondere etwa 2 Gew.-% (jeweils be­ zogen auf die Zubereitung).Phospholipids based on soybean oil (soya bean Phospholipids) are provided. In the process, the soybean phospholi amount of pid up to about 3 wt .-% amount. Preferably they 1 to 3.5 wt .-% and in particular about 2 wt .-% (each be drew on the preparation).

Neben den Soya-Phospholipiden können noch ein oder mehrere der folgenden Bestandteile vorliegen:In addition to the soy phospholipids, one or more of the following components are present:

  • - bis zu 5 Gew.-% Lyso-Phosphatidylcholin und- Up to 5 wt .-% lyso-phosphatidylcholine and
  • - bis zu 1 Gew.-% andere Phospholipide (bezogen auf Soya-Phospholipide).- Up to 1 wt .-% other phospholipids (based on soy phospholipids).

So können ein oder mehrere der folgenden Bestandteile als andere Phospholipide vorgesehen werden:So can one or more of the following ingredients than others Phospholipids are provided:

  • - Phosphatidsäure,- phosphatidic acid,
  • - Phosphatidylinositol,- phosphatidylinositol,
  • - Sterine (auch in Form üblicher Derivate),- sterols (also in the form of common derivatives),
  • - N-Acyl-phosphatidyl-ethanolamin und- N-acyl-phosphatidyl-ethanolamine and
  • - übliche Lipidfraktion.- usual lipid fraction.

Der Gehalt an Öl und/oder Fett kann insgesamt bis zu etwa 5 Gew.-% betragen. Vorzugsweise beträgt er 1 bis 4 Gew.-% und ins­ besondere etwa 3 Gew.-% (jeweils bezogen auf die Zubereitung).The content of oil and / or fat may total up to about 5 Wt .-% amount. It is preferably 1 to 4 wt .-% and ins particular about 3 wt .-% (in each case based on the preparation).

Bei dem Öl und/oder Fett kann es sich um Fettsäuren handeln, die gesättigt oder ungesättigt sein können. So können mehrere der folgenden Bestandteile als Öl bzw. Fett vorgesehen werden:The oil and / or fat may be fatty acids which can be saturated or unsaturated. So can several of the following components are provided as oil or fat:

  • - 10 bis 30 Gew.-%, insbesondere 10 bis 20 Gew.-% Palmitin oder Stearinsäure,- 10 to 30 wt .-%, in particular 10 to 20 wt .-% palmitin or stearic acid,
  • - 5 bis 15 Gew.-%, insbesondere 8 bis 12 Gew.-% Ölsäure,From 5 to 15% by weight, in particular from 8 to 12% by weight, of oleic acid,
  • - 5 bis 70 Gew.-%, insbesondere 62 bis 66 Gew.-% Linolsäure und- 5 to 70 wt .-%, in particular 62 to 66 wt .-% linoleic acid and
  • - 5 bis 10 Gew.-%, insbesondere 6 bis 8 Gew.-% Linolensäure (wobei sich die Mengen der einzelnen Komponenten jeweils zu 100% ergänzen).- 5 to 10 wt .-%, in particular 6 to 8 wt .-% linolenic acid (where the amounts of each component to each 100% complete).

Die erfindungsgemäße Zubereitung kann ferner durch einen Gehalt an Vitaminen wie Vitamin A und/oder Vitamin E, an D-Panthenol und/oder alpha-Bisabolol gekennzeichnet sein. The preparation of the invention may further by a content on vitamins such as vitamin A and / or vitamin E, on D-panthenol and / or alpha-bisabolol.  

Sie kann ferner durch einen Gehalt an Blutdialysat, beispiels­ weise Philocell, gekennzeichnet sein. Das Blutdialysat kann in Mengen von bis zu etwa 2 Vol.-% vorliegen.It can also by a content of blood dialysate, for example Philocell. The blood dialysate can be in Quantities of up to about 2 vol .-% are present.

Die erfindungsgemäße Zubereitung liegt als Emulsion vor. Wenn es beim Lagern zu einer Entmischung bzw. "Aufrahmung" kommt, läßt sich Homogenität durch Schütteln ohne weiteres erneut erzielen.The preparation according to the invention is in the form of an emulsion. If it when storing a demixing or "creaming" comes leaves Homogeneity by shaking easily achieve again.

Nachstehend wird die Erfindung durch ein Beispiel näher erläu­ tert.The invention will be explained in more detail by way of example below tert.

Beispiel 1example 1

Es wurde eine Zubereitung in Form einer Mikroemulsion aus Phospholipid-Liposomen (Bilayer-Vesikel) mit einer mittleren Teilchengröße von 150 bis 200 nm hergestellt. Die Zusammen­ setzung der Zubereitung bestand aus:It was a preparation in the form of a microemulsion Phospholipid liposomes (bilayer vesicles) with a middle Particle size of 150 to 200 nm produced. The together The preparation of the preparation consisted of:

Ethanolethanol etwa 20 Vol.-%about 20% by volume gereinigte Soya-Phospholipidepurified soy phospholipids etwa 2 Gew.-%about 2% by weight mit @With @ Lyso-PhosphatidylcholinLysophosphatidylcholine max. 5%Max. 5% und @and @ andere Phospholipideother phospholipids max. 1%Max. 1% (Phosphatidylethanolamin, Phosphatidsäure, Phosphaticylinositol, Sterine und Sterinderivate, N-Acyl-phosphatidyl-ethanolamin sowie untergeordnete Mengen sonstiger Lipidfraktionen)(Phosphatidylethanolamine, phosphatidic acid, phosphaticylinositol, sterols and sterol derivatives, N-acyl-phosphatidyl-ethanolamine and minor amounts of other lipid fractions)

Restölgehalt (Fettsäuren)Residual oil content (fatty acids) max. 3%Max. 3% und zwar als Gesamt-Fettsäuren (%): @as total fatty acids (%): @ Palmitin- und StearinsäurePalmitic and stearic acid 20%20% Ölsäureoleic acid 10%10% Linolsäurelinoleic acid 62%62% Linolensäurelinolenic 8%8th% Vitamin A (Palmintat) @Vitamin A (Palmintate) @ Vitamin E (Acetat) @Vitamin E (acetate) @ D-Panthenol @D-panthenol @ alpha-Bisabolol @alpha-bisabolol @ Philocell (Blutdialysat; Pentapharm AG, Basel)Philocell (blood dialysate; Pentapharm AG, Basel) <2%<2% Rest WasserRest of water

Das Präparat neigte bei Raumtemperatur nach 2 bis 4 Tagen zur Aufrahmung, die sich durch einfaches Schütteln wieder beheben ließ.The preparation tended to warm at room temperature after 2 to 4 days Creaming, which can be remedied by simply shaking left.

Die Mindesthaltbarkeit bei 18°C betrug etwa 4 Monate.The minimum shelf life at 18 ° C was about 4 months.

Bei brüchigem Haar ließ sich bei täglicher Anwendung bereits nach 4 Wochen eine deutliche Kräftigung nachgewachsener Partien beobachten.For brittle hair was already in daily use After 4 weeks, a clear strengthening of regrown lots observe.

Claims (12)

1. Wässerige Zubereitung zur Kräftigung und Regeneration des Haarwuchses, gekennzeichnet durch einen Gehalt an
  • - Ethanol,
  • - Phospholipide und
  • - Öle und/oder Fette.
1. Aqueous preparation for strengthening and regenerating hair growth, characterized by a content of
  • Ethanol,
  • - Phospholipids and
  • - oils and / or fats.
2. Zubereitung nach Anspruch 1, gekennzeichnet durch einen Etha­ nolgehalt bis zu etwa 25 Vol.-%, vorzugsweise 5 bis 20 Vol.-% und insbesondere etwa 20 Vol.-% (bezogen auf die Zubereitung).2. Preparation according to claim 1, characterized by an etha nol content up to about 25% by volume, preferably 5 to 20% by volume. and in particular about 20% by volume (based on the preparation). 3. Zubereitung nach Anspruch 1 oder 2, gekennzeichnet durch Phospholipide auf Basis von Soyabohnenöl (Soya-Phospholipide).3. Preparation according to claim 1 or 2, characterized by Soybean oil-based phospholipids (soya phospholipids). 4. Zubereitung nach Anspruch 3, gekennzeichnet durch eine Soya- Phospholipidmenge bis zu etwa 3 Gew.-%, vorzugsweise 1 bis 2,5 Gew.-% und insbesondere etwa 2 Gew.-% (bezogen auf die Zuberei­ tung).4. Preparation according to claim 3, characterized by a soya Phospholipidmenge up to about 3 wt .-%, preferably 1 to 2.5 Wt .-% and in particular about 2 wt .-% (based on the Zuberei tung). 5. Zubereitung nach einem der vorhergehenden Ansprüche, dadurch gekennzeichnet, daß neben den Soya-Phospholipiden noch ein oder mehrere der folgenden Bestandteile vorliegen:
  • - bis zu 5 Gew.-% Lyso-Phosphatidylcholin und
  • - bis zu 1 Gew.-% andere Phospholipide (bezogen auf Soya-Phospholipide).
5. Preparation according to one of the preceding claims, characterized in that in addition to the soy phospholipids one or more of the following constituents are present:
  • - Up to 5 wt .-% lyso-phosphatidylcholine and
  • - Up to 1 wt .-% other phospholipids (based on soy phospholipids).
6. Zubereitung nach Anspruch 5, gekennzeichnet durch einen oder mehrere der folgenden Bestandteile als andere Phospholipide:
  • - Phosphatidsäure,
  • - Phosphatidylinositol,
  • - Sterine (auch in Form üblicher Derivate),
  • - N-Acyl-phosphatidyl-ethanolamin und
  • - übliche Lipidfraktion.
6. Preparation according to claim 5, characterized by one or more of the following constituents as other phospholipids:
  • - phosphatidic acid,
  • - phosphatidylinositol,
  • - sterols (also in the form of common derivatives),
  • - N-acyl-phosphatidyl-ethanolamine and
  • - usual lipid fraction.
7. Zubereitung nach einem der vorhergehenden Ansprüche, gekenn­ zeichnet durch einen Gehalt an Öl und/oder Fett von insgesamt bis zu etwa 5 Gew.-%, vorzugsweise 1 bis 4 Gew.-% und insbeson­ dere etwa 3 Gew.-% (bezogen auf die Zubereitung).7. Preparation according to one of the preceding claims, marked characterized by a total content of oil and / or fat up to about 5 wt .-%, preferably 1 to 4 wt .-% and in partic dere about 3 wt .-% (based on the preparation). 8. Zubereitung nach Anspruch 7, dadurch gekennzeichnet, daß es sich bei dem Öl und/oder Fett um Fettsäuren handelt, die gesät­ tigt oder ungesättigt sein können.8. Preparation according to claim 7, characterized in that it the oil and / or fat are fatty acids that are sown may be unsaturated or unsaturated. 9. Zubereitung nach Anspruch 7 oder 8, gekennzeichnet durch meh­ rere der folgenden Bestandteile als Öl bzw. Fett:
  • - 10 bis 30 Gew.-% und insbesondere 10 bis 20 Gew.-% Palmitin- oder Stearinsäure,
  • - 5 bis 15 Gew.-% und insbesondere 8 bis 12 Gew.-% Ölsäure,
  • - 5 bis 70 Gew.-% und insbesondere 62 bis 66 Gew.-% Linolsäure und
  • - 5 bis 10 Gew.-% und insbesondere 6 bis 8 Gew.-% Linolensäure (sich jeweils zu 100% ergänzend).
9. A preparation according to claim 7 or 8, characterized by meh rere of the following ingredients as oil or fat:
  • From 10 to 30% by weight and in particular from 10 to 20% by weight of palmitic or stearic acid,
  • From 5 to 15% by weight and in particular from 8 to 12% by weight of oleic acid,
  • From 5 to 70% by weight and in particular from 62 to 66% by weight of linoleic acid and
  • - 5 to 10 wt .-% and in particular 6 to 8 wt .-% linolenic acid (in each case to 100% complementary).
10. Zubereitung nach einem der vorhergehenden Ansprüche, gekenn­ zeichnet durch einen zusätzlichen Gehalt an Vitaminen, insbeson­ dere Vitamin A und/oder Vitamin E, D-Panthenol und/oder alpha- Bisabolol.10. Preparation according to one of the preceding claims, marked characterized by an additional content of vitamins, in particular vitamin A and / or vitamin E, D-panthenol and / or alpha- Bisabolol. 11. Zubereitung nach einem der vorhergehenden Ansprüche, gekenn­ zeichnet durch einen zusätzlichen Gehalt an Blutdialysat. 11. Preparation according to one of the preceding claims, marked characterized by an additional content of blood dialysate.   12. Zubereitung nach Anspruch 11, gekennzeichnet durch einen Blutdialysatgehalt von bis zu etwa 2 Vol.-%, beispielsweise von Philocell.12. A preparation according to claim 11, characterized by a Blutdialysatgehalt of up to about 2 vol .-%, for example of Philo Cell.
DE19914113346 1991-04-24 1991-04-24 Aq. lotion for strengthening and regeneration of hair-growth - comprises ethanol@, phospholipid(s) (derived from soya bean oil) oil, and/or grease Ceased DE4113346A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE19914113346 DE4113346A1 (en) 1991-04-24 1991-04-24 Aq. lotion for strengthening and regeneration of hair-growth - comprises ethanol@, phospholipid(s) (derived from soya bean oil) oil, and/or grease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19914113346 DE4113346A1 (en) 1991-04-24 1991-04-24 Aq. lotion for strengthening and regeneration of hair-growth - comprises ethanol@, phospholipid(s) (derived from soya bean oil) oil, and/or grease

Publications (1)

Publication Number Publication Date
DE4113346A1 true DE4113346A1 (en) 1992-10-29

Family

ID=6430249

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19914113346 Ceased DE4113346A1 (en) 1991-04-24 1991-04-24 Aq. lotion for strengthening and regeneration of hair-growth - comprises ethanol@, phospholipid(s) (derived from soya bean oil) oil, and/or grease

Country Status (1)

Country Link
DE (1) DE4113346A1 (en)

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0608511A3 (en) * 1992-12-03 1994-09-07 Barbara Arena Utilization of lysolecithins in the treatment of male impotence and alopecia and the relevant compositions suitable for such use
EP0692972A4 (en) * 1993-04-02 1998-05-06 Anticancer Inc Method for delivering beneficial compositions to hair follicles
DE19803193C1 (en) * 1998-01-28 1999-07-15 August Wolff Gmbh & Co Arzneim Use of lecithin and alpha-bisabolol mixtures
WO2001012141A1 (en) * 1999-08-18 2001-02-22 Kyowa Hakko Kogyo Co., Ltd. Hair growth stimulants
EP1252878A3 (en) * 2001-02-16 2003-03-12 Kyowa Hakko Kogyo Co., Ltd. Hair-growing agent
US6562804B2 (en) 2001-02-16 2003-05-13 Kyowa Hakko Kogyo Co., Ltd. Hair-growing agent
US6733776B1 (en) 1992-04-02 2004-05-11 Anticancer, Inc. Method for promoting hair growth
US6844326B2 (en) 1995-06-07 2005-01-18 Anticancer, Inc. Treatment of alopecia
FR2870125A1 (en) * 2004-05-12 2005-11-18 Dermaconcept Jmc Sarl FORMULATION OF THE SPOT-ON TYPE USEFUL IN COSMETOLOGY AND DERMATOLOGY
DE102007048140A1 (en) 2007-10-05 2009-04-09 Henkel Ag & Co. Kgaa Oxidative hair treatment with reduced hair damage
US7556825B2 (en) 1993-04-02 2009-07-07 Anticancer, Inc. Method for promoting hair growth
WO2009095028A1 (en) * 2008-01-30 2009-08-06 Mohamed Hamdi Hasan Badrawi Ointment on the basis of a dialysate of calves' blood.
WO2011081862A1 (en) * 2009-12-15 2011-07-07 Mcneil-Ppc, Inc. Methods of reducing hair loss and / or facilitating hair growth and / or regrowth
WO2011081861A3 (en) * 2009-12-15 2013-04-11 Mcneil-Ppc, Inc. Hair growth and / or regrowth compositions
FR3004947A1 (en) * 2013-04-26 2014-10-31 Hitex ASSOCIATION OF MILIACIN AND POLAR LIPIDS, IN PARTICULAR SPHINGOLIPIDS AND / OR PHOSPHOLIPIDS, FOR THE CARE OF HAIR AND SCALP
EP2572700A4 (en) * 2010-05-19 2016-02-17 Biopid Corp Composition for preventing hair-loss or stimulating hair growth

Cited By (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6733776B1 (en) 1992-04-02 2004-05-11 Anticancer, Inc. Method for promoting hair growth
EP0608511A3 (en) * 1992-12-03 1994-09-07 Barbara Arena Utilization of lysolecithins in the treatment of male impotence and alopecia and the relevant compositions suitable for such use
EP0692972A4 (en) * 1993-04-02 1998-05-06 Anticancer Inc Method for delivering beneficial compositions to hair follicles
US5914126A (en) * 1993-04-02 1999-06-22 Anticancer, Inc. Methods to deliver macromolecules to hair follicles
US5965157A (en) * 1993-04-02 1999-10-12 Anticancer Inc. Method to provide for production of hair coloring pigments in hair follicles
US6224901B1 (en) 1993-04-02 2001-05-01 Anticancer, Inc. Method for delivering beneficial compositions to hair follicles
US6261596B1 (en) 1993-04-02 2001-07-17 Anticancer, Inc. Method to provide for production of hair coloring pigments in hair follicles
US7556825B2 (en) 1993-04-02 2009-07-07 Anticancer, Inc. Method for promoting hair growth
US6844326B2 (en) 1995-06-07 2005-01-18 Anticancer, Inc. Treatment of alopecia
DE19803193C1 (en) * 1998-01-28 1999-07-15 August Wolff Gmbh & Co Arzneim Use of lecithin and alpha-bisabolol mixtures
WO2001012141A1 (en) * 1999-08-18 2001-02-22 Kyowa Hakko Kogyo Co., Ltd. Hair growth stimulants
US7015209B2 (en) 1999-08-18 2006-03-21 Kyowa Hakko Kogyo Co., Ltd. Hair-growing agent
EP1252878A3 (en) * 2001-02-16 2003-03-12 Kyowa Hakko Kogyo Co., Ltd. Hair-growing agent
EP1232740A3 (en) * 2001-02-16 2003-07-02 Kyowa Hakko Kogyo Co., Ltd. Hair-growing agent
US6562803B2 (en) 2001-02-16 2003-05-13 Kyowa Hakko Kogyo Co., Ltd. Hair-growing agent
US6562804B2 (en) 2001-02-16 2003-05-13 Kyowa Hakko Kogyo Co., Ltd. Hair-growing agent
FR2870125A1 (en) * 2004-05-12 2005-11-18 Dermaconcept Jmc Sarl FORMULATION OF THE SPOT-ON TYPE USEFUL IN COSMETOLOGY AND DERMATOLOGY
WO2005115335A1 (en) * 2004-05-12 2005-12-08 Dermaconcept Jmc Spot-on formulation useful for cosmetology and dermatology
DE102007048140A1 (en) 2007-10-05 2009-04-09 Henkel Ag & Co. Kgaa Oxidative hair treatment with reduced hair damage
WO2009047022A1 (en) 2007-10-05 2009-04-16 Henkel Ag & Co. Kgaa Oxidative hair treatment with reduced damage to hair
WO2009095028A1 (en) * 2008-01-30 2009-08-06 Mohamed Hamdi Hasan Badrawi Ointment on the basis of a dialysate of calves' blood.
US8470833B2 (en) 2009-12-15 2013-06-25 Mcneil-Ppc, Inc. Hair growth and/or regrowth compositions
WO2011081861A3 (en) * 2009-12-15 2013-04-11 Mcneil-Ppc, Inc. Hair growth and / or regrowth compositions
WO2011081862A1 (en) * 2009-12-15 2011-07-07 Mcneil-Ppc, Inc. Methods of reducing hair loss and / or facilitating hair growth and / or regrowth
US8470880B2 (en) 2009-12-15 2013-06-25 Mcneil-Ppc, Inc. Methods of reducing hair loss and/or facilitating hair growth and/or regrowth
US8871773B2 (en) 2009-12-15 2014-10-28 Mcneil-Ppc, Inc. Methods of reducing hair loss and/or facilitating hair growth and/or regrowth
US8877762B2 (en) 2009-12-15 2014-11-04 Mcneil-Ppc, Inc. Hair growth and/or regrowth compositions
US8927554B2 (en) 2009-12-15 2015-01-06 Mcneil-Ppc, Inc. Hair growth and/or regrowth compositions
US9636296B2 (en) 2009-12-15 2017-05-02 Johnson & Johnson Consumer Inc. Methods of reducing hair loss and/or facilitating hair growth and/or regrowth
US10064811B2 (en) 2009-12-15 2018-09-04 Johnson & Johnson Consumer Inc. Methods of reducing hair loss and/or facilitating hair growth and/or regrowth
US10646429B2 (en) 2009-12-15 2020-05-12 Johnson & Johnson Consumer Inc. Methods of reducing hair loss and/or facilitating hair growth and/or regrowth
EP2572700A4 (en) * 2010-05-19 2016-02-17 Biopid Corp Composition for preventing hair-loss or stimulating hair growth
FR3004947A1 (en) * 2013-04-26 2014-10-31 Hitex ASSOCIATION OF MILIACIN AND POLAR LIPIDS, IN PARTICULAR SPHINGOLIPIDS AND / OR PHOSPHOLIPIDS, FOR THE CARE OF HAIR AND SCALP
EP2821052A1 (en) * 2013-04-26 2015-01-07 Hitex Combination of miliacin and polar lipids, in particular of sphingolipids and/or phospholipids, for care of the hair and scalp

Similar Documents

Publication Publication Date Title
DE4113346A1 (en) Aq. lotion for strengthening and regeneration of hair-growth - comprises ethanol@, phospholipid(s) (derived from soya bean oil) oil, and/or grease
DE69630821T2 (en) FRACTIONATED VEGETARIAN OIL
DE68914856T2 (en) Synergistic antioxidant mixture.
DE3302898C2 (en)
US5079227A (en) Perfume composition, with a continuous aqueous phase, having a high concentration of perfume
DE2718797C3 (en) Process for the production of flowable oil-containing purified phosphatidylcholine
DE3111364C2 (en)
EP0557825B1 (en) Bath and shower additives with vesicle forming properties, preparation and use thereof
DE2350315A1 (en) PHARMACEUTICAL AND COSMETIC PREPARATIONS FOR EXTERNAL USE
DE2241016B2 (en) Emulsifier combination for creams from T ^ p water in oil and their use
EP0148303B1 (en) Dietetic composition
DE4119890A1 (en) COSMETIC AND PHARMACEUTICAL OIL COMPONENTS
DE4015108A1 (en) STABLE EMULSION FOR APPLICATION OF PHARMACOLOGICALLY ACTIVE ACTIVE SUBSTANCES
DE2433173C3 (en) Use of cholanic acid derivatives
DE1492952C3 (en) Anti-splash preparations for edible fats containing water
DE19922193B4 (en) Water-soluble concentrate consisting of essential oils microencapsulated in a liposome system, a process for its preparation and its use
EP0283977B1 (en) Emulsifying suppository bases and suppositories made therefrom
DE3042365C2 (en) Liquid, lecithin-containing single-phase multi-component systems and processes for their preparation
DE2715286A1 (en) EMULGATERS MADE FROM PHOSPHATIDYLCHOLINE AND PHOSPHATIDYL-N, N-DIMETHYL-AETHANOLAMINE
WO1993015715A1 (en) Asthma or lung aerosol preparations containing lecithin
DE68903930T2 (en) LIPID EMULSION FOR TREATING AIDS.
DE69100869T2 (en) Fat based products.
DE4021084C1 (en) Fumarate topical compsn. contg. liposome(s) improving bio-availability - esp. for treating psoriasis, contain liposomal structure, alcohol, stabiliser and fumaric acid (deriv.) and are stable and non irritant
DE69429719T2 (en) Inclusion of a water-soluble active ingredient in a lipid
DE69505656T2 (en) LIPOSOME FORMING COMPOSITIONS

Legal Events

Date Code Title Description
8131 Rejection